Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

Market Nav

News Details

26/05/2026 13:30

Marksans Pharma Q4 net profit zooms 144.53% at Rs 91.92 cr

The company reported standalone net profit of Rs 91.92 crore for the quarter ended March 31, 2026 as compared to Rs 37.59 crore in the same period last year, registering a year-on-year growth of 144.53 per cent.

Net revenue of the company rose substantially by 20.78 per cent at Rs 361.57 crore in January-March quarter of this fiscal as against Rs 299.36 crore in the corresponding period last year.

During January-March quarter, operating expenses increased by 2.73 per cent to Rs 255.58 crore from Rs 248.78 crore in year ago period.

Other Income grew by 251.41 per cent at Rs 27.48 crore versus (Mar'25 Rs 7.82 crore).

Operating Profit surged by 109.59 per cent to Rs 105.99 crore as against Rs 50.57 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 73.53 per cent in March quarter.

Interest grew by 12.90 per cent y-o-y to Rs 0.35 crore, while Taxation increased by 163.53 per cent at Rs 32.44 crore (Mar'25 Rs 12.31 crore).